ARTICLE | Company News
Cell Pathways other research news
December 14, 1998 8:00 AM UTC
CLPA said that Prevatac inhibits a novel cyclic GMP phosphodiesterase leading to inhibition of cell growth and induction of apoptosis, but does not inhibit cyclooxygenase (COX) pathways. The compound ...